Regorafenib Plus Nivolumab in Patients with Mismatch Repair-Proficient/microsatellite Stable Metastatic Colorectal Cancer: a Single-Arm, Open-Label, Multicentre Phase 2 Study
ECLINICALMEDICINE(2023)
Key words
Regorafenib,Nivolumab,Microsatellite stable,Mismatch repair-proficient,Metastatic colorectal cancer
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined